SGC, HitGen collaborate on DEL technology for drug discovery
HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…
Amicus gets FDA approval for Pombiliti + Opfolda to treat Pompe disease
29 Sep 23The FDA has cleared the muscle disorder therapy only for adult LOPD patients whose weight is ≥40kg and…
Scynexis recalls Brexafemme tablets over potential cross contamination risk
29 Sep 23Scynexis has recalled the drug over potential risk of cross contamination with a non-antibacterial ß-lactam drug substance in…
FDA approves Fabre-Kramer’s Exxua for major depressive disorder
29 Sep 23The drug’s mechanism of targeted single serotonin (5HT) 1a receptor agonism reduced depressive symptoms with an acceptable side…
Nestlé sets target to boost sales of its more nutritious foods and steps up support for balanced diets
29 Sep 23Nestlé aims to grow the sales of its more nutritious products by CHF 20-25 billion by 2030. This represents about…
QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness
29 Sep 23AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified content, providing complete…
Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”
29 Sep 23Unlocking the AI Revolution - A Symposium on the future of the Healthcare Industry and Diagnostic Imaging in…
InfectoGnostics study: Benefits of on-site tests in general practices
29 Sep 23Interview with Anni Matthes and Dr. Robby Markwart, Research associates, Institute of General Practice and Family Medicine at…
Rockstar Energy Drink Partners with Rising Mexican Artist Joaquín Nava to Launch “Proud Hasta Los Huesos,” a Celebration of Día de los Muertos
29 Sep 23Rockstar Debuts Limited-Edition Cans Inspired by the Vibrant Iconography of the Longstanding Mexican Holiday Featuring Rockstar Pure Zero,…
Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept to Treat Adults with PAH
29 Sep 23If approved, sotatercept would be the first in its class, bringing a novel approach to address a rare…